The United States’ drugs scene is a very competitive one and there are always some new drugs being launched in the market. More pen Laboratories Limited on Monday informed the exchanges that it has developed and added three drugs to its portfolio of Active Pharmaceutical Ingredients for sale in domestic and global markets.
The three bulk drugs are Rivaroxaban (Cardiac Segment), Vildagliptin (Diabetes Segment) and UDCA (for Liver a....
Tags : Rivaroxaban (Cardiac Segment), Vildagliptin (Diabetes Segment) and UDCA (for Liver ailments), Active Pharmaceutical Ingredients,
comments (0)